美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kalaris Therapeutics Inc.

3.16

-0.0200-0.63%

成交量：4.33萬

成交額：13.93萬

市值：7,518.36萬

市盈率：-1.53

高：3.27

開：3.20

低：3.13

收：3.18

52周最高：11.88

52周最低：3.03

股本：2,379.23萬

流通股本：723.08萬

量比：0.56

換手率：0.60%

股息：- -

股息率：- -

每股收益(TTM):-2.0646

每股收益(LYR):-2.8500

淨資產收益率：-79.91%

總資產收益率：-31.03%

市淨率：1.30

市盈率(LYR):-1.11

資料載入中...

總覽公司新聞資訊公告

Kalaris Therapeutics Inc. 第二季度運營虧損低於預期，錄得1238.6萬美元

Kalaris Therapeutics 四個月後41%患者需再次治療，六個月內29%無需額外干預

Kalaris Therapeutics公布TH103治療新生血管性年齡相關性黃斑變性的1a期擴展隊列積極結果

新聞稿：Kalaris任命勞裏·基廷加入董事會

Kalaris宣佈將在美國視網膜專家學會公布TH103一期a階段臨床數據一期B/二期臨床試驗正積極招募

Kalaris Therapeutics Inc. 第一季度營業虧損達1183.3萬美元

Kalaris Therapeutics Inc任命Brett Hagen為首席財務官，自2026年4月14日起生效

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/KLRS/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"KLRS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLRS\",,,,,undefined,":{"symbol":"KLRS","market":"US","secType":"STK","nameCN":"Kalaris Therapeutics Inc.","latestPrice":3.16,"timestamp":1789675200000,"preClose":3.18,"halted":0,"volume":43336,"delay":0,"changeRate":-0.0062893081761006345,"floatShares":7230800,"shares":23792278,"eps":-2.064571,"marketStatus":"盤前交易","change":-0.02,"latestTime":"09-18 07:35:11 EDT","open":3.2,"high":3.27,"low":3.13,"amount":139322,"amplitude":0.044025,"askPrice":3.55,"askSize":100,"bidPrice":2.84,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.064571,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789738200000},"marketStatusCode":1,"adr":0,"listingDate":1596081600000,"exchange":"NASDAQ","adjPreClose":3.16,"postHourTrading":{"tag":"盘后","latestPrice":3.16,"preClose":3.16,"latestTime":"16:10 EDT","volume":7,"amount":22.12,"timestamp":1789675804221,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.563299728365838},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLRS\",,,,,undefined,":{"symbol":"KLRS","floatShares":7230800,"roa":"-31.03%","roe":"-79.91%","lyrEps":-2.849999,"volumeRatio":0.563299728365838,"shares":23792278,"dividePrice":0,"high":3.27,"amplitude":0.044025,"preClose":3.18,"low":3.13,"week52Low":3.03,"pbRate":"1.30","week52High":11.88,"institutionHeld":0,"latestPrice":3.16,"eps":-2.064571,"divideRate":0,"volume":43336,"delay":0,"ttmEps":-2.064571,"open":3.2,"prevYearClose":8.44,"prevWeekClose":3.38,"prevMonthClose":4.04,"prevQuarterClose":4.07,"fiveDayClose":3.3,"twentyDayClose":4.17,"sixtyDayClose":4.47},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KLRS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"KLRS","fiscalQuarterEnding":"2026/06","expectedEps":-0.5,"name":null,"time":"盤前","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.48},{"market":"US","date":"2026-05-12","symbol":"KLRS","fiscalQuarterEnding":"2026/03","expectedEps":-0.52,"name":null,"time":"盤前","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"pre","actualEps":-0.46},{"market":"US","date":"2026-03-17","symbol":"KLRS","fiscalQuarterEnding":"2025/12","expectedEps":-0.56,"name":null,"time":"盤前","type":"earning","dateTimestamp":1773720000000,"reportTimeType":"pre","actualEps":-0.44},{"market":"US","date":"2025-11-12","symbol":"KLRS","fiscalQuarterEnding":"2025/09","expectedEps":-0.66,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.64},{"market":"US","date":"2025-08-13","symbol":"KLRS","fiscalQuarterEnding":"2025/06","expectedEps":-0.51,"name":null,"time":"盤前","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":-0.61}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KLRS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KLRS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.375,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.375,"analysts":8,"updateTime":1781582400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KLRS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KLRS","date":"2026-09-17","current":-1.530584,"percent":0.633423,"low":-3.702314,"twenty":-2.973625,"median":-2.118396,"eighty":-0.88122,"high":-0.558935,"avg":-1.980297,"sd":0.951472,"marketCap":75699839},"quantilePoints":[{"date":"2025-03-28","current":-2.436259,"twenty":-2.629862,"median":-2.463299,"eighty":-2.415709,"marketCap":168508741},{"date":"2025-04-04","current":-2.000923,"twenty":-2.457891,"median":-2.325397,"eighty":-2.168027,"marketCap":138397856},{"date":"2025-04-11","current":-1.976588,"twenty":-2.405434,"median":-2.167216,"eighty":-1.951712,"marketCap":136714639},{"date":"2025-04-17","current":-1.811647,"twenty":-2.361089,"median":-2.042834,"eighty":-1.880868,"marketCap":125306167},{"date":"2025-04-25","current":-1.762976,"twenty":-2.268073,"median":-1.954956,"eighty":-1.818136,"marketCap":121939732},{"date":"2025-05-02","current":-1.581811,"twenty":-2.177762,"median":-1.903581,"eighty":-1.797045,"marketCap":109409116},{"date":"2025-05-09","current":-1.041021,"twenty":-2.168027,"median":-1.865726,"eighty":-1.715927,"marketCap":72004290},{"date":"2025-05-16","current":-0.871644,"twenty":-2.131794,"median":-1.821111,"eighty":-1.36225,"marketCap":66206559},{"date":"2025-05-23","current":-0.696822,"twenty":-2.051217,"median":-1.811647,"eighty":-0.924751,"marketCap":52927842},{"date":"2025-05-30","current":-0.728832,"twenty":-1.996056,"median":-1.784607,"eighty":-0.873072,"marketCap":55359157},{"date":"2025-06-06","current":-0.765766,"twenty":-1.972262,"median":-1.721064,"eighty":-0.77266,"marketCap":58164519},{"date":"2025-06-13","current":-0.679587,"twenty":-1.946844,"median":-1.576403,"eighty":-0.758379,"marketCap":51618673},{"date":"2025-06-20","current":-0.632803,"twenty":-1.914397,"median":-1.295192,"eighty":-0.733756,"marketCap":48065214},{"date":"2025-06-27","current":-0.630341,"twenty":-1.911693,"median":-0.990998,"eighty":-0.714058,"marketCap":47878190},{"date":"2025-07-03","current":-0.615567,"twenty":-1.898714,"median":-0.913935,"eighty":-0.685496,"marketCap":46756045},{"date":"2025-07-11","current":-0.615567,"twenty":-1.891143,"median":-0.871644,"eighty":-0.649054,"marketCap":46756045},{"date":"2025-07-18","current":-0.595869,"twenty":-1.870593,"median":-0.816242,"eighty":-0.639205,"marketCap":45259851},{"date":"2025-07-25","current":-0.699285,"twenty":-1.8614,"median":-0.765766,"eighty":-0.634773,"marketCap":53114867},{"date":"2025-08-01","current":-0.659888,"twenty":-1.83436,"median":-0.758379,"eighty":-0.635266,"marketCap":50122480},{"date":"2025-08-08","current":-0.667275,"twenty":-1.817055,"median":-0.738681,"eighty":-0.635266,"marketCap":50683552},{"date":"2025-08-15","current":-0.558935,"twenty":-1.812188,"median":-0.724523,"eighty":-0.632803,"marketCap":42454488},{"date":"2025-08-22","current":-0.563436,"twenty":-1.811647,"median":-0.714058,"eighty":-0.627879,"marketCap":46007948},{"date":"2025-08-29","current":-0.815379,"twenty":-1.792178,"median":-0.714058,"eighty":-0.615567,"marketCap":66580608},{"date":"2025-09-05","current":-1.067322,"twenty":-1.785689,"median":-0.715289,"eighty":-0.622954,"marketCap":87153267},{"date":"2025-09-12","current":-0.980287,"twenty":-1.771628,"median":-0.728832,"eighty":-0.627879,"marketCap":80046349},{"date":"2025-09-19","current":-1.005482,"twenty":-1.753242,"median":-0.746068,"eighty":-0.629356,"marketCap":82103615},{"date":"2025-09-26","current":-1.092517,"twenty":-1.715927,"median":-0.758379,"eighty":-0.630341,"marketCap":89210533},{"date":"2025-10-03","current":-1.623887,"twenty":-1.652483,"median":-0.783002,"eighty":-0.631818,"marketCap":132600143},{"date":"2025-10-10","current":-1.059306,"twenty":-1.715927,"median":-0.815379,"eighty":-0.632803,"marketCap":86498683},{"date":"2025-10-17","current":-1.097097,"twenty":-1.652483,"median":-0.853303,"eighty":-0.634281,"marketCap":89584582},{"date":"2025-10-24","current":-1.120001,"twenty":-1.598641,"median":-0.878784,"eighty":-0.635266,"marketCap":91454824},{"date":"2025-10-31","current":-1.085645,"twenty":-1.578566,"median":-0.913935,"eighty":-0.635266,"marketCap":88649461},{"date":"2025-11-07","current":-1.083355,"twenty":-1.543053,"median":-0.93448,"eighty":-0.63822,"marketCap":88462437},{"date":"2025-11-14","current":-1.220778,"twenty":-1.513949,"median":-0.991739,"eighty":-0.641667,"marketCap":99683887},{"date":"2025-11-21","current":-2.326591,"twenty":-1.652483,"median":-1.007772,"eighty":-0.642652,"marketCap":129046684},{"date":"2025-11-28","current":-2.104047,"twenty":-1.7661,"median":-1.019224,"eighty":-0.643637,"marketCap":116703088},{"date":"2025-12-05","current":-1.996147,"twenty":-1.811647,"median":-1.04043,"eighty":-0.647085,"marketCap":110718314},{"date":"2025-12-12","current":-2.808768,"twenty":-1.83375,"median":-1.046709,"eighty":-0.650039,"marketCap":155791141},{"date":"2025-12-19","current":-3.513489,"twenty":-1.853956,"median":-1.059878,"eighty":-0.652009,"marketCap":194879195},{"date":"2025-12-26","current":-3.230252,"twenty":-1.885652,"median":-1.065031,"eighty":-0.655456,"marketCap":179169164},{"date":"2026-01-02","current":-2.845859,"twenty":-1.914397,"median":-1.075338,"eighty":-0.657426,"marketCap":157848407},{"date":"2026-01-09","current":-2.785165,"twenty":-1.996147,"median":-1.083355,"eighty":-0.657426,"marketCap":154481972},{"date":"2026-01-16","current":-2.987477,"twenty":-2.104047,"median":-1.089081,"eighty":-0.657426,"marketCap":165703423},{"date":"2026-01-23","current":-3.29769,"twenty":-2.164782,"median":-1.092517,"eighty":-0.659396,"marketCap":182909648},{"date":"2026-01-30","current":-3.102121,"twenty":-2.196152,"median":-1.097097,"eighty":-0.661858,"marketCap":172062245},{"date":"2026-02-06","current":-2.815512,"twenty":-2.367922,"median":-1.114275,"eighty":-0.662351,"marketCap":156165190},{"date":"2026-02-13","current":-3.02794,"twenty":-2.502772,"median":-1.122292,"eighty":-0.662351,"marketCap":167947713},{"date":"2026-02-20","current":-3.702314,"twenty":-2.785165,"median":-1.136034,"eighty":-0.665305,"marketCap":205352549},{"date":"2026-02-27","current":-3.560695,"twenty":-2.810117,"median":-1.145196,"eighty":-0.674662,"marketCap":197497534},{"date":"2026-03-06","current":-3.262285,"twenty":-2.841832,"median":-1.152067,"eighty":-0.679587,"marketCap":180945894},{"date":"2026-03-13","current":-3.092005,"twenty":-2.933528,"median":-1.165399,"eighty":-0.681064,"marketCap":171501173},{"date":"2026-03-20","current":-2.932075,"twenty":-2.973316,"median":-1.284909,"eighty":-0.685003,"marketCap":127363466},{"date":"2026-03-27","current":-3.072027,"twenty":-2.992198,"median":-1.357057,"eighty":-0.692882,"marketCap":133442723},{"date":"2026-04-02","current":-3.132729,"twenty":-3.014452,"median":-1.458617,"eighty":-0.697807,"marketCap":136079478},{"date":"2026-04-10","current":-3.203987,"twenty":-3.059472,"median":-1.52082,"eighty":-0.701747,"marketCap":139174799},{"date":"2026-04-17","current":-3.478464,"twenty":-3.075922,"median":-1.602849,"eighty":-0.708887,"marketCap":151097516},{"date":"2026-04-24","current":-3.219822,"twenty":-3.095853,"median":-1.746752,"eighty":-0.714058,"marketCap":139862648},{"date":"2026-05-01","current":-2.913675,"twenty":-3.10064,"median":-1.776394,"eighty":-0.714058,"marketCap":126564232},{"date":"2026-05-08","current":-2.725961,"twenty":-3.095853,"median":-1.811647,"eighty":-0.715043,"marketCap":118410298},{"date":"2026-05-15","current":-2.72166,"twenty":-3.087959,"median":-1.820952,"eighty":-0.717998,"marketCap":120019759},{"date":"2026-05-22","current":-2.669521,"twenty":-3.080541,"median":-1.83767,"eighty":-0.723661,"marketCap":117720529},{"date":"2026-05-29","current":-2.700804,"twenty":-3.078518,"median":-1.841041,"eighty":-0.729817,"marketCap":119100067},{"date":"2026-06-05","current":-2.429681,"twenty":-3.07722,"median":-1.863022,"eighty":-0.734741,"marketCap":107144076},{"date":"2026-06-12","current":-2.352359,"twenty":-3.072027,"median":-1.890061,"eighty":-0.741636,"marketCap":103734332},{"date":"2026-06-18","current":-2.45487,"twenty":-3.072027,"median":-1.911693,"eighty":-0.753455,"marketCap":108254864},{"date":"2026-06-26","current":-2.319987,"twenty":-3.071774,"median":-1.965772,"eighty":-0.758379,"marketCap":102306795},{"date":"2026-07-02","current":-2.44408,"twenty":-3.063682,"median":-1.990247,"eighty":-0.758379,"marketCap":107779019},{"date":"2026-07-10","current":-2.422498,"twenty":-3.057285,"median":-2.077072,"eighty":-0.760349,"marketCap":106827328},{"date":"2026-07-17","current":-2.487242,"twenty":-3.052473,"median":-2.104047,"eighty":-0.764781,"marketCap":109682401},{"date":"2026-07-24","current":-2.114965,"twenty":-3.046817,"median":-2.114965,"eighty":-0.793344,"marketCap":93265729},{"date":"2026-07-31","current":-1.877571,"twenty":-3.035018,"median":-2.104047,"eighty":-0.807625,"marketCap":82797127},{"date":"2026-08-07","current":-2.260639,"twenty":-3.007709,"median":-2.112878,"eighty":-0.814247,"marketCap":99689644},{"date":"2026-08-14","current":-2.08558,"twenty":-2.992198,"median":-2.117831,"eighty":-0.818113,"marketCap":92314038},{"date":"2026-08-21","current":-2.215768,"twenty":-2.988826,"median":-2.131838,"eighty":-0.837815,"marketCap":98076521},{"date":"2026-08-28","current":-2.205011,"twenty":-2.983431,"median":-2.16316,"eighty":-0.854016,"marketCap":97600422},{"date":"2026-09-04","current":-2.118962,"twenty":-2.978711,"median":-2.160644,"eighty":-0.865734,"marketCap":93791625},{"date":"2026-09-11","current":-1.774765,"twenty":-2.976168,"median":-2.131838,"eighty":-0.8745,"marketCap":78556437},{"date":"2026-09-17","current":-1.710228,"twenty":-2.973625,"median":-2.118396,"eighty":-0.88122,"marketCap":75699839}],"updateTime":1789731305554},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KLRS\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1178929389","title":"Kalaris Therapeutics Inc. 第二季度運營虧損低於預期，錄得1238.6萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1178929389","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178929389?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 20:15","pubTimestamp":1786450532,"startTime":"0","endTime":"0","summary":"Kalaris Therapeutics Inc. 公布的第二季度运营数据出炉。本季度运营支出为1238.6万美元，而运营收入则为-1238.6万美元。\n对比业内普遍预期（IBES预估为-1250万美元），公司实际亏损略低于这一数字，展现出相对稳健的财务表现。\n这一数据为投资者提供了关于公司近期经营状况的重要参考。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLRS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194705815","title":"Kalaris Therapeutics 四個月後41%患者需再次治療，六個月內29%無需額外干預","url":"https://stock-news.laohu8.com/highlight/detail?id=1194705815","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194705815?lang=zh_tw&edition=fundamental","pubTime":"2026-07-17 19:02","pubTimestamp":1784286160,"startTime":"0","endTime":"0","summary":"Kalaris Therapeutics公布的数据显示，在接受其疗法后四个月或更晚时间点，有41%的患者需要接受再次治疗。然而，在为期六个月的观察期内，有29%的患者未再需要任何额外的治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123151126","title":"Kalaris Therapeutics公布TH103治療新生血管性年齡相關性黃斑變性的1a期擴展隊列積極結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1123151126","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123151126?lang=zh_tw&edition=fundamental","pubTime":"2026-07-17 19:01","pubTimestamp":1784286076,"startTime":"0","endTime":"0","summary":"Kalaris Therapeutics Inc. (KLRS) 宣布，其候选药物TH103在治疗新生血管性年龄相关性黄斑变性的1a期临床试验扩展队列中，取得了积极的初步数据。结果显示，TH103表现出良好的安全性与耐受性特征，并为后续临床开发提供了支持性依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLRS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165872790","title":"新聞稿：Kalaris任命勞裏·基廷加入董事會","url":"https://stock-news.laohu8.com/highlight/detail?id=1165872790","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165872790?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 04:07","pubTimestamp":1783368475,"startTime":"0","endTime":"0","summary":"新泽西州伯克利高地，2026年7月6日——致力于研发和商业化治疗常见视网膜疾病的临床阶段生物制药公司Kalaris Therapeutics, Inc.今日宣布，任命劳里·基廷加入其董事会，自2026年8月1日起生效。伴随基廷女士的任命公告，莫拉娜·约万-埃姆比里科斯将辞去董事会职务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLRS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130870385","title":"Kalaris宣佈將在美國視網膜專家學會公布TH103一期a階段臨床數據 一期B/二期臨床試驗正積極招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1130870385","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130870385?lang=zh_tw&edition=fundamental","pubTime":"2026-06-23 20:02","pubTimestamp":1782216174,"startTime":"0","endTime":"0","summary":"Kalaris Therapeutics Inc. 宣布，其候选药物TH103的一期a阶段临床数据即将在美国视网膜专家学会年会上公布。与此同时，该药物后续的一期B/二期临床试验也正在积极进行患者招募工作。目前正在推进的一期B/二期临床试验旨在进一步评估TH103的疗效与安全性，其积极招募状态也反映了公司对该项目持续推进的决心。业内普遍关注此类创新疗法的临床进展，因其可能为存在未满足医疗需求的视网膜疾病患者带来新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187520500","title":"Kalaris Therapeutics Inc. 第一季度營業虧損達1183.3萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1187520500","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187520500?lang=zh_tw&edition=fundamental","pubTime":"2026-05-12 20:16","pubTimestamp":1778588187,"startTime":"0","endTime":"0","summary":"Kalaris Therapeutics Inc. 最新财报数据显示，该公司第一季度营业费用为1183.3万美元，导致同期营业亏损达到同等数额。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199365025","title":"Kalaris Therapeutics Inc任命Brett Hagen為首席財務官，自2026年4月14日起生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1199365025","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199365025?lang=zh_tw&edition=fundamental","pubTime":"2026-04-11 04:24","pubTimestamp":1775852653,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会（SEC）的文件，生物制药公司Kalaris Therapeutics Inc. (KLRS) 已正式任命Brett Hagen先生担任公司首席财务官（Principal Financial Officer），此项任命将于2026年4月14日正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLRS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}]}}